期刊文献+

化疗脑发病机制及治疗的研究进展 被引量:5

Research Progress on Chemo-brain:Pathogenesis and Treatment with Integrated Traditional Chinese Medicine and Western Medicine
原文传递
导出
摘要 化疗脑,即化疗相关认知损害,是化疗引起的副反应之一。15%~45%恶性肿瘤患者化疗后出现化疗脑。目前有关化疗脑的发病机制尚无明确定论,可能与海马区神经细胞受损、DNA损伤、炎症反应和化疗药物的毒性作用等因素相关。目前临床治疗上主要采用药物治疗和认知行为治疗等方法来治疗化疗脑。中医诊疗化疗脑中医治法根据辨证可分为益气健脾、滋阴补肾、疏肝解郁等,以达到养神而恢复认知功能的目的。全文综述化疗脑近年的中西医研究进展,以期为临床诊治提供一定的思路。 'Chemo-brain',or chemotherapy-induced cognitive impairment,is one of the adverse effects of chemotherapy,which occurs in 15%~45%of cancer patients after chemotherapy.The pathogenesis of chemo-brain is still controversial,which may be related to the hippocampal neuron injury,DNA damage,inflammation,chemotherapeutic drugs toxicity or other factors.The drug therapy and cognitive behavioral therapy are mainly used in the treatment of chemo-brain.According to the syndrome differentiation of traditional Chinese medicine,the principles of'nourishing qi to invigorate spleen','enriching yin and nourishing kidney'and'soothing liver and relieving depression'are applied to achieve'nourishing spirit'and restoring cognitive function.This article reviews the recent progress on chemo-brain research with Chinese and western medicine to provide some ideas for clinical diagnosis and treatment.
作者 李帅 谢长生 LI Shuai;XIE Chang-sheng(The First Clinical Medical College,Zhejiang Chinese Medical University,Hangzhou 310053,China;The First Affiliated Hospital of Zhejiang Chinese Medical University,Hangzhou 310006,China)
出处 《肿瘤学杂志》 CAS 2019年第4期355-358,共4页 Journal of Chinese Oncology
关键词 化疗脑 化疗相关认知损害 发病机制 中西医治疗 ,chemo-brain chemotherapy-induced cognitive impairment pathogenesis Chinese and western medicine treatment
  • 相关文献

参考文献4

二级参考文献60

  • 1王勇,顾教伟,王大斌.托莫西汀对哌甲酯治疗无效的注意缺陷多动障碍患儿的疗效和安全性分析[J].湖北医药学院学报,2011,30(6):597-599. 被引量:5
  • 2Silberfarb PM.Chemotherapy and cognitive defects in cancer patients[J].Annu Rev Med,1983,34:35-46.
  • 3Janelsins MC,Kohli S,Mohile SG,et al.An update on cancer-and chemotherapy-related cognitive dysfunction:current status[J].Semin Oncol,2011,38(3):431-438.
  • 4van Dam FS,Schagen SB,Muller MJ,et al.Impairment of cognitive function in women receiving adjuvant treatment for high-risk breast cancer:High-dose versus standard-dose chemotherapy[J].J Natl Cancer Inst,1998,90:210-218.
  • 5Brezden CB,Phillips KA,Abdolell M,et al.Cognitive function in breast cancer patients receiving adjuvant chemotherapy[J].J Clin Oncol,2000,18(14):2695-2701.
  • 6Ahles TA,Saykin AJ,Furstenberg CT,et al.Neuropsychologic impact of standard-dose systemic chemotherapy in long term survivors of breast cancer and lymphoma[J].J Clin Oncol,2002,20(2):485-493.
  • 7Wefel JS,Lenzi R,Theriault RL,et al.The cognitive sequelae of standard-dose adjuvant chemotherapy in women with breast carcinoma:Results of a prospective,randomized,longitudinal trial[J].Cancer,2004,100(11):2292-2299.
  • 8Janelsins MC,Kesler SR,Ahles TA,et al.Prevalence,mechanisms,and management of cancer-related cognitive impairment[J].Int Rev Psychiatry,2014,26(1):102-113.
  • 9Seigers R,Fardell JE.Neurobiological basis of chemotherapyinduced cognitive impairment:A review of rodent research[J].Neurosci Biobehav Rev,2011,35(3):729-741.
  • 10Seigers R,Schagen SB,Van Tellingen O,et al.Chemotherapy-related cognitive dysfunction:current animal studies and future directions[J].Brain Imaging Behav,2013,7(4):453-459.

共引文献22

同被引文献38

引证文献5

二级引证文献44

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部